Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRETIS-TNK II: Intra-arterial Tenecteplase during Thrombectomy
NCT05657444Phase 3Completed
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Mar 2023
- Primary completion
- Mar 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by General Hospital of the Northern Theater Command. Started Mar 2023; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05657444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05657444.